Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: Final results of the HOPE (HEPACOAT and an antithrombotic regimen of aspirin alone) study

Roxana Mehran, Eve D. Aymong, Dale T. Ashby, Tim Fischell, Hall Whitworth, Robert Siegel, William Thomas, S. Chiu Wong, Raj Narasimaiah, Alexandra J. Lansky, Martin B. Leon

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Abstract

Background - Stent thrombosis is an infrequent complication of intracoronary stenting that often has devastating clinical consequences. This study assesses the additional benefit of heparin coating with the BX VELOCITY Balloon-Expandable Stent with HEPACOAT, Carmeda end-point attached heparin (HEPACOAT) in patients with de novo or restenotic native coronary artery lesions treated with aspirin monotherapy after optimal stenting. Methods and Results - This was a multicenter, prospective, nonrandomized, pilot study. Two hundred patients (69% men; mean age, 64.1±11.2 years) meeting the eligibility criteria were treated with the HEPACOAT stent and aspirin alone after stenting. Any other antiplatelet or anticoagulation therapy was not permitted. Procedural success was achieved in all patients. There were 3 postprocedural non-Q-wave myocardial infarctions. The primary end point of stent thrombosis at 30 days occurred in 2 of 200 patients (1%): in one after blunt chest trauma and in the other in the setting of essential thrombocytosis. Major adverse cardiac events (death, myocardial infarction, target lesion revascularization, and coronary artery bypass grafting) were observed at 30 days in 5 of 200 (2.5%) patients. Conclusions - The BX VELOCITY stent with HEPACOAT and aspirin alone after the procedure was safe in select patients with de novo or restenotic lesions in native coronary arteries. Heparin coating provides additional protection against stent thrombosis.

Original languageEnglish
Pages (from-to)1078-1083
Number of pages6
JournalCirculation
Volume108
Issue number9
DOIs
StatePublished - 2 Sep 2003
Externally publishedYes

Keywords

  • Angioplasty
  • Heparin
  • Stents
  • Thrombosis

Fingerprint

Dive into the research topics of 'Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: Final results of the HOPE (HEPACOAT and an antithrombotic regimen of aspirin alone) study'. Together they form a unique fingerprint.

Cite this